$5.93
0.061.02%
At Close: -
$5.88
-0.05-0.93%
After Hours: 4:28 PM EDT
15 minutes delayed
Comments
Loading...
Inovio Pharmaceuticals (INO) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestInovio Pharmaceuticals (NASDAQ:INO) Stock Quotes, Forecast and News Summary
Inovio Pharmaceuticals Stock (NASDAQ: INO) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Inovio Pharmaceuticals (INO) stock?
You can purchase shares of Inovio Pharmaceuticals (NASDAQ:INO) through any online brokerage.
Who are Inovio Pharmaceuticals (INO) competitors?
Other companies in Inovio Pharmaceuticals’s space includes: Molecular Partners (NASDAQ:MOLN), Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT) and Adverum Biotechnologies (NASDAQ:ADVM).
What is the forecast, or price target, for Inovio Pharmaceuticals (INO) stock?
Inovio Pharmaceuticals has a consensus price target of $17.00.
What is the current price for Inovio Pharmaceuticals (INO)?
The stock price for Inovio Pharmaceuticals (NASDAQ: INO) is $5.88 last updated September 24, 2024 at 4:28 PM EDT.
Does Inovio Pharmaceuticals (INO) pay a dividend?
There are no upcoming dividends for Inovio Pharmaceuticals.
When is Inovio Pharmaceuticals (NASDAQ:INO) reporting earnings?
Inovio Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Inovio Pharmaceuticals (INO) going to split?
There is no upcoming split for Inovio Pharmaceuticals.
What sector and industry does Inovio Pharmaceuticals (INO) operate in?
Inovio Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.